DermaSensor Inc.

Award-winning FDA-cleared AI bringing skin cancer detection to non-specialist clinicians

https://wefunder.com/dermasensor

Total raised on Wefunder: 699999

Total investors: 3

Quick facts

  • First & only automated skin cancer detection tool cleared by the FDA for Primary Care Physicians
  • $1M contracted ARR at year-end 2025 driven by 3X growth in paid devices YoY
  • 40K lesions scanned, 9 published clinical studies; device cuts physicians missed cancers by 50-68%
  • $20M raised including Pier 70 Ventures, Kern Venture Group & GenHenn Venture
  • Exited unicorn co-founder ($1.65B to Stryker); leadership from Genentech, Optum, & Abbott
  • 10 US health systems & 100s of practices under contract; Class 2b CE Mark in Europe; 5 patents
  • TIME Best Invention, Inc. Best in Innovation, Edison & SXSW winner; Forbes & CBS features
  • $8B+ US & European market across 1.5M+ frontline clinicians evaluating suspicious lesions

Team profiles

Featured investor profiles

Invest in DermaSensor Inc.

Award-winning FDA-cleared AI bringing skin cancer detection to non-specialist clinicians

EARLY BIRD TERMS: $500,000 LEFT

$699,999

of a $749,999 goal
INVESTMENT TERMS
Preferred Stock
 $72.4M  $65.8M pre-money valuation
Early Bird Bonus: The first $500K of investments will be at $0.14 per share and a $65.8M pre-money valuation

Ask

Ask a Question